Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ENVB
ENVB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ENVB ETF News Today | Earnings, Events & Price Alerts
ENVB News
Enveric Biosciences Patent Challenge Withdrawn
Feb 25 2026
stocktwits
Enveric Biosciences Patent Challenge Withdrawn
Feb 25 2026
Benzinga
Weekly Roundup: Cannabis and Psychedelic Sector Developments
Feb 23 2026
Yahoo Finance
Enveric Biosciences Reveals New Data on EB-003
Feb 19 2026
Benzinga
Enveric Biosciences Closes Direct Offering of Common Stock
Jan 28 2026
Yahoo Finance
Enveric Biosciences Announces Direct Offering of Shares
Jan 28 2026
seekingalpha
Enveric Secures U.S. Patent Expanding Neuropsychiatric Drug Development
Dec 29 2025
Newsfilter
ENvue Appoints David Johnson as Chairman to Drive Feeding Tube Technology Advancement
Dec 15 2025
Newsfilter
Enveric Biosciences Exercises 426,390 Warrants at $7.05 Each, Raising $3.1 Million
Dec 12 2025
Newsfilter
Enveric Biosciences Exercises 426,390 Warrants at $7.05 Each
Dec 11 2025
Newsfilter
What Caused Enveric Biosciences (ENVB) to Soar 74% in After-Hours Trading?
Dec 10 2025
Benzinga
Stock Splits Scheduled for This Week (October 27 to October 31) – Keep Your Investments Active
Oct 26 2025
TipRanks
Weekly Update on the Cannabis and Psychedelic Industries
Oct 19 2025
Yahoo Finance
Enveric Biosciences Achieves Important Manufacturing Milestones for Upcoming IND and Clinical Trials
Oct 02 2025
Newsfilter
Enveric Biosciences Reports Completion of Warrant Exercise, Generating $2.2 Million in Gross Proceeds
Sep 18 2025
Newsfilter
Enveric Biosciences Receives FDA Feedback on Pre-IND Type B Meeting Request for Lead Program EB-003
Sep 16 2025
NASDAQ.COM
Show More News
